Abstract:Due to vigorous alloimmunity, an allograft is usually rejected without any conventional immunosuppressive treatment. However, continuous global immunosuppression may cause severe side effects, including tumors and infections. Mounting evidence has shown that cyclosporine (CsA), a common immunosuppressant used in clinic, impedes allograft tolerance by dampening regulatory T cells (Tregs), although it inhibits allograft rejection at the same time. Therefore, it is necessary to seek an alternative immunosuppressive drug that spares Tregs with high efficiency in suppression but low toxicity. In this study, we investigated the capacity of emodin, an anthraquinone molecule originally extracted from certain natural plants, to prolong transplant survival in a mouse model and explored the cellular and molecular mechanisms underlying its action. We found that emodin significantly extended skin allograft survival and hindered CD3(+) T cell infiltration in the allograft, accompanied by an increase in CD4(+)Foxp3(+) and CD8(+)CD122(+) Treg frequencies and numbers but a reduction in effector CD8(+)CD44(high)CD62L(low) T cells in recipient mice. Emodin also inhibited effector CD8(+) T cells proliferation in vivo. However, CD4(+)CD25(+), but not CD8(+)CD122(+), Tregs derived from emodin-treated recipients were more potent in suppression of allograft rejection than those isolated from control recipients, suggesting that emodin also enhances the suppressive function of CD4(+)CD25(+) Tregs. Interestingly, depleting CD25(+) Tregs largely reversed skin allograft survival prolonged by emodin while depleting CD122(+) Tregs only partially abrogated the same allograft survival. Furthermore, we found that emodin hindered dendritic cell (DC) maturation and reduced alloantibody production posttransplantation. Finally, we demonstrated that emodin inhibited in vitro proliferation of T cells and blocked their mTOR signaling as well. Therefore, emodin may be a novel mTOR inhibitor that suppresses alloimmunity by inducing both CD4(+)FoxP3(+) and CD8(+)CD122(+) Tregs, suppressing alloantibody production, and hindering DC maturation. Thus, emodin is a newly emerging immunosuppressant and could be utilized in clinical transplantation in the future.

Retraction: A Novel Immunosuppressant, Luteolin, Modulates Alloimmunity and Suppresses Murine Allograft Rejection

Luteolin Attenuates Acute Liver Allograft Rejection in Rats by Inhibiting T Cell Proliferation and Regulating T Cell Subsets

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

Corrigendum: A New Immunosuppressive Molecule Emodin Induces Both CD4+FoxP3+ and CD8+CD122+ Regulatory T Cells and Suppresses Murine Allograft Rejection

Helper T Cell (CD4 + ) Targeted Tacrolimus Delivery Mediates Precise Suppression of Allogeneic Humoral Immunity

The Critical Role of Induced CD4+ FoxP3+ Regulatory Cells in Suppression of Interleukin-17 Production and Attenuation of Mouse Orthotopic Lung Allograft Rejection.

Topical inhibition of T cell costimulatory pathways in draining lymph nodes may suppress allograft rejection.

Targeted regulation of lymphocytic ER stress response with an overall immunosuppression to alleviate allograft rejection

The new immunosuppressant PLNPK prolongs allograft survival in mice.

Medicinal Herbs Fructus Corni and Semen Cuscutae Suppress Allograft Rejection Via Distinct Immune Mechanisms.

CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival.

Artemisinin Attenuates Transplant Rejection by Inhibiting Multiple Lymphocytes and Prolongs Cardiac Allograft Survival

Shikonin Prolongs Allograft Survival Via Induction of CD4+FoxP3+ Regulatory T Cells.

L6H21 Prolonged Rats Survival after Limb Allotransplantation by Inhibiting Acute Rejection.

Prevention of Graft-Versus-host Disease by a Novel Immunosuppressant LLT, Through Expansion of Regulatory T Cells

Immunosuppressive effect and mechanism of Triptolide on skin allografts in mice

An Immunotherapeutic Strategy for Prolonging Graft Survival in Mice.

In Vivo Attenuation of Antibody-Mediated Acute Renal Allograft Rejection by Ex Vivo TGF-β-Induced CD4+Foxp3+ Regulatory T Cells

Electrostimulation Suppresses Allograft Rejection Via Promoting Lymphatic Regulatory T Cell Migration Mediated by Lymphotoxin (Lt)-Ltβ Receptor Signaling

Immunomodulatory effects of OX40Ig gene-modified adipose tissue-derived mesenchymal stem cells on rat kidney transplantation

Electrostimulation suppresses allograft rejection via promoting lymphatic regulatory T cell migration mediated by lymphotoxin - lymphotoxin receptor β signaling